Trademark Attorney / Law Firm

MICHAEL J COSTELLO – Trademark Portfolio

MICHAEL J COSTELLO specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 5 of 10 total filings concentrated in this category. The practice also covers Class 31 (Natural Agricultural Products) along with 4 other Nice Classification classes. Currently, 0 trademarks are registered.

10 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

MICHAEL J COSTELLO's trademark practice covers 4 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

31
Natural Agricultural Products (3 filings)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademark applications has MICHAEL J COSTELLO filed?

MICHAEL J COSTELLO has filed 10 trademark applications with the United States Patent and Trademark Office (USPTO).

What trademark classes does MICHAEL J COSTELLO specialize in?

MICHAEL J COSTELLO has filed trademarks across 4 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 31 (Natural Agricultural Products), Class 35 (Advertising & Business), Class 9 (Computers & Electronics). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is MICHAEL J COSTELLO's trademark registration success rate?

MICHAEL J COSTELLO has a 0% trademark registration rate, with 0 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.